What’s new

• CRISIL confirmed a 'D' rating after GKB resumed sharing financial data.
• The company has posted negative operating profits for seven consecutive years.
• Bank limits are nearly fully drawn for the twelve months through April 2026.

Why it matters

The debt in default represents roughly 44% of the company's total market capitalization. This rating action removes any ambiguity regarding the firm's ability to service its obligations and will likely choke off remaining access to working capital.

What we’re watching

• Any potential recovery plans from the board to address the liquidity crunch.
• The reaction of lenders regarding the formal default classification.
• Whether the company can sustain operations with fully drawn credit lines.

The full read

GKB Ophthalmics is in default. CRISIL has confirmed a 'D' rating on the company's ₹15.1 crore in bank facilities, ending a period of non-cooperation where the agency lacked sufficient data to assess the firm. The default status is a severe blow for a company with a market capitalization of only ₹34 crore, as the debt represents 44% of its total value. The company's financial health is fragile, marked by seven consecutive years of negative operating profits and bank limits that have been nearly fully drawn for the twelve months through April 2026. This confirmation removes any doubt about the firm's ability to service its debt. The rating action will likely constrain future access to working capital and further strain relationships with lenders and suppliers, leaving the company in a precarious liquidity position.

Primary source: BSE · NSE